Uncommon
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $30M
Investors
- 6
About Uncommon
Based in Cambridge, UK, and founded in 2017, Uncommon operates as a biotechnology research firm that develops bacon and pork belly from animal cells. The company was Co-founded by Benjamina Bollag (CEO) and Ruth Faram (Chief scientific officer)., and Betagro Ventures, acquired Uncommon from Balderton Capital, Global Brain, Lowercarbon Capital, and Redalpine. Financial terms of the transaction were not disclosed. The company offers healthy protein and produces meat using cells. It uses a small sample of cells from an animal and makes them grow by nurturing them. The firm develops cells to produce lab-grown pork belly and bacon strips. The acquisition aims to support Meatable’s further development of its capabilities by integrating Uncommon Bio’s non-GMO mRNA reprogramming and saRNA differentiation technologies.
Who invested in Uncommon
6 investors across 1 round
See all investors in Uncommon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 6, 2023
Amount
$30M
Investors
Questions about Uncommon
Who invested in Uncommon?
Uncommon has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Uncommon raised?
Uncommon has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Uncommon last raise money?
Uncommon's most recent round on record is a Series A, in Apr 2023.
What does Uncommon do?
Based in Cambridge, UK, and founded in 2017, Uncommon operates as a biotechnology research firm that develops bacon and pork belly from animal cells.
Where is Uncommon headquartered?
Uncommon is headquartered in Cambridge, UK.
Which VCs invest in companies like Uncommon?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Uncommon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Uncommon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.